Tuberculosis: The drug development pipeline at a glanceVILLEMAGNEA, Baptiste; CRAUSTEA, Celine; FLIPOA, Marion et al.European journal of medicinal chemistry. 2012, Vol 51, pp 1-16, issn 0223-5234, 16 p.Article

Is chemical synthetic accessibility computationally predictable for drug and lead-like molecules? A comparative assessment between medicinal and computational chemistsBONNET, Pascal.European journal of medicinal chemistry. 2012, Vol 54, pp 679-689, issn 0223-5234, 11 p.Article

Use of gene networks from full genome microarray libraries to identify functionally relevant drug-affected genes and gene regulation cascadesSAVOIE, Christopher J; ABURATANI, Sachiyo; WATANABE, Shouji et al.DNA research. 2003, Vol 10, Num 1, pp 19-25, issn 1340-2838, 7 p.Article

Crystallizing new approaches for antimicrobial drug discoverySCHMID, Molly B.Biochemical pharmacology. 2006, Vol 71, Num 7, pp 1048-1056, issn 0006-2952, 9 p.Article

Discovery of veterinary antiparasitic agents in the 21st Century: A view from industryWOODS, Debra J; KNAUER, Christopher S.International journal for parasitology. 2010, Vol 40, Num 10, pp 1177-1181, issn 0020-7519, 5 p.Conference Paper

Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug designLI DI; KEEFER, Christopher; OBACH, R. Scott et al.European journal of medicinal chemistry. 2012, Vol 57, pp 441-448, issn 0223-5234, 8 p.Article

Evaluation of online extraction/mass spectrometry for in vivo cassette analysisSADAGOPAN, Nalini; PABST, Brandon; COHEN, Lucinda et al.Journal of chromatography. B. 2005, Vol 820, Num 1, pp 59-67, issn 1570-0232, 9 p.Article

The Discovery of Medicines from Plants: A Current Biological PerspectiveMILLER, James S.Economic botany. 2011, Vol 65, Num 4, pp 396-407, issn 0013-0001, 12 p.Article

Target-based drug discovery, genetic diseases, and biologiesHURKO, Orest.Neurochemistry international. 2012, Vol 61, Num 6, pp 892-898, issn 0197-0186, 7 p.Article

Synthesis and biological evaluation of imidazo[4,5-b]pyridine and 4-heteroaryl-pyrimidine derivatives as anti-cancer agentsLUKASIK, Pawel M; ELABAR, Sherifa; LAM, Frankie et al.European journal of medicinal chemistry. 2012, Vol 57, pp 311-322, issn 0223-5234, 12 p.Article

Comparative psychology and the grand challenge of drug discovery in psychiatry and neurodegenerationBRUNNER, Dani; BALCI, Fuat; LUDVIG, Elliot A et al.Behavioural processes. 2012, Vol 89, Num 2, pp 187-195, issn 0376-6357, 9 p.Article

Hydrosoluble formazan XTT: its application to natural products drug discovery for LeishmaniaWILLIAMS, Cornelly; ESPINOSA, Omar A; MONTENEGRO, Hector et al.Journal of microbiological methods. 2003, Vol 55, Num 3, pp 813-816, issn 0167-7012, 4 p.Article

Literature mining in support of drug discoveryAGARWAL, Pankaj; SEARLS, David B.Briefings in bioinformatics. 2008, Vol 9, Num 6, pp 479-492, issn 1467-5463, 14 p.Article

A rapidly diverging superfamily of peptide toxins in venomous Gemmula speciesHERALDE, Francisco M; IMPERIAL, Julita; BANDYOPADHYAY, Pradip K et al.Toxicon (Oxford). 2008, Vol 51, Num 5, pp 890-897, issn 0041-0101, 8 p.Article

Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantagesBIBBY, M. C.European journal of cancer (1990). 2004, Vol 40, Num 6, pp 852-857, issn 0959-8049, 6 p.Article

Protein phosphorylation analysis based on proton release detection: Potential tools for drug discoveryBHALLA, Nikhil; DI LORENZO, Mirella; PULA, Giordano et al.Biosensors & bioelectronics. 2014, Vol 54, pp 109-114, issn 0956-5663, 6 p.Article

Human models of pain for the prediction of clinical analgesiaLÖTSCH, Jörn; OERTEL, Bruno G; ULTSCH, Alfred et al.Pain (Amsterdam). 2014, Vol 155, Num 10, pp 2014-2021, issn 0304-3959, 8 p.Article

Renal fibrosis and proteomics: Current knowledge and still key open questions for proteomic investigationPRUNOTTO, Marco; GHIGGERI, Gianmarco; BRUSCHI, Maurizio et al.Journal of proteomics (Print). 2011, Vol 74, Num 10, pp 1855-1870, issn 1874-3919, 16 p.Article

Integrated high capacity solid phase extraction-MS/MS system for pharmaceutical profiling in drug discoveryKERNS, Edward H; KLEINTOP, Teresa; LITTLE, David et al.Journal of pharmaceutical and biomedical analysis. 2004, Vol 34, Num 1, pp 1-9, issn 0731-7085, 9 p.Article

Current approaches to exploit actinomycetes as a source of novel natural productsGENILLOUD, Olga; GONZALEZ, Ignacio; SALAZAR, Oscar et al.Journal of industrial microbiology & biotechnology. 2011, Vol 38, Num 3, pp 375-389, issn 1367-5435, 15 p.Article

Drugs from hidden bugs : their discovery via untapped resourcesLEFEVRE, Fabrice; ROBE, Patrick; JARRIN, Cyrille et al.Research in microbiology (Paris). 2008, Vol 159, Num 3, pp 153-161, issn 0923-2508, 9 p.Article

Micromechanical measurement of membrane receptor binding for label-free drug discoveryYIFEI ZHANG; VENKATACHALAN, Srinivasan P; HAO XU et al.Biosensors & bioelectronics. 2004, Vol 19, Num 11, pp 1473-1478, issn 0956-5663, 6 p.Article

Discovery of Novel Drugs for Promising TargetsMARTELL, Robert E; BROOKS, David G; YAN WANG et al.Clinical therapeutics. 2013, Vol 35, Num 9, pp 1271-1281, issn 0149-2918, 11 p.Article

Genomic approaches to small molecule discoverySTEGMAIER, K.Leukemia. 2009, Vol 23, Num 7, pp 1226-1235, issn 0887-6924, 10 p.Article

Synthesis of (3R, 4S)-3,4,5-trihydroxy-4-methylpentylphosphonic acid as a potential inhibitor of the nonmevalonate pathwayYOSHIOKA, Toshiaki; SHIMIZU, Hiroki; OHRUI, Hiroshi et al.Bioscience, biotechnology, and biochemistry. 2004, Vol 68, Num 6, pp 1259-1264, issn 0916-8451, 6 p.Article